These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1758823

  • 1. Experience with a controlled-release oral morphine for cancer pain management.
    Kim BS, Chung HC.
    Postgrad Med J; 1991; 67 Suppl 2():S82-6. PubMed ID: 1758823
    [Abstract] [Full Text] [Related]

  • 2. A clinical survey of controlled-release morphine sulphate for cancer pain relief in a Japanese hospice.
    Tsuneto S, Hayashi A, Miyazaki M, Kashiwagi T.
    Postgrad Med J; 1991; 67 Suppl 2():S79-81. PubMed ID: 1758822
    [Abstract] [Full Text] [Related]

  • 3. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY, Qiu H, Ma ZS, Chen J, Zhang Y, Chen LZ, Wang DL, Ma ZY.
    Zhonghua Yi Xue Za Zhi; 2004 Mar 17; 84(6):450-5. PubMed ID: 15061959
    [Abstract] [Full Text] [Related]

  • 4. Guidelines for the use of MS Contin tablets in the management of cancer pain.
    Warfield CA.
    Postgrad Med J; 1991 Mar 17; 67 Suppl 2():S9-12; discussion S13. PubMed ID: 1758825
    [Abstract] [Full Text] [Related]

  • 5. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA.
    Clin Ther; 2006 Jan 17; 28(1):86-98. PubMed ID: 16490582
    [Abstract] [Full Text] [Related]

  • 6. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, Villari P, Ficorella C, Gebbia V, Riina S, Casuccio A, Mangione S.
    Eur J Pain; 2008 Nov 17; 12(8):1040-6. PubMed ID: 18353696
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Guidelines for use of controlled-release oral morphine in cancer pain management. Correlation with clinical experience.
    Lapin J, Portenoy RK, Coyle N, Houde RW, Foley KM.
    Cancer Nurs; 1989 Aug 17; 12(4):202-8. PubMed ID: 2766263
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
    Mystakidou K, Befon S, Kouskouni E, Gerolymatos K, Georgaki S, Tsilika E, Vlahos L.
    Anticancer Res; 2001 Aug 17; 21(3C):2225-30. PubMed ID: 11501851
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.